Bayer Execs Roth And Eckhardt On Current And Future Pharma Growth
Nubeqa, Kerendia Driving Revenue; New Launches On The Way
Scrip spoke with Bayer commercial and business development heads Christine Roth and Jurgen Eckhardt about sales growth, product launches and dealmaking priorities in 2025 and beyond.
